Education
About Us
Working with TipRanks
Follow Us
Apyx Medical Corporation (APYX)
NASDAQ:APYX
Total Valuation
Apyx Medical has a market cap or net worth of $63.12M. The enterprise value is $27.82M.
Market Cap$63.12M
Enterprise Value$27.82M
Share Statistics
Apyx Medical has 37,793,884 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding37,793,884
Owned by Insiders1.81%
Owned by Institutions31.42%
Financial Efficiency
Apyx Medical’s return on equity (ROE) is -1.65 and return on invested capital (ROIC) is -34.97%.
Return on Equity (ROE)-1.65
Return on Assets (ROA)-0.36
Return on Invested Capital (ROIC)-34.97%
Return on Capital Employed (ROCE)-0.35
Revenue Per Employee218.65K
Profits Per Employee-107.09K
Employee Count220
Asset Turnover0.74
Inventory Turnover2.48
Valuation Ratios
The current PE Ratio of Apyx Medical is -2.39. Apyx Medical’s PEG ratio is -0.14.
PE Ratio-2.39
PS Ratio0.00
PB Ratio4.88
Price to Fair Value3.95
Price to FCF-4.11
Price to Operating Cash Flow-4.13
PEG Ratio-0.14
Income Statement
In the last 12 months, Apyx Medical had revenue of 48.10M and earned -23.46M in profits. Earnings per share was -0.66.
Revenue48.10M
Gross Profit29.36M
Operating Income-18.84M
Pretax Income-23.31M
Net Income-23.46M
EBITDA-16.80M
Earnings Per Share (EPS)-0.66
Cash Flow
In the last 12 months, operating cash flow was -12.41M and capital expenditures -742.00K, giving a free cash flow of -13.15M billion.
Operating Cash Flow-12.41M
Free Cash Flow-13.15M
Free Cash Flow per Share-0.35
Dividends & Yields
Apyx Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.00
52-Week Price Change4.37%
50-Day Moving Average1.25
200-Day Moving Average1.33
Relative Strength Index (RSI)61.15
Average Volume (3m)323.52K
Important Dates
Apyx Medical upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date―
Financial Position
Apyx Medical as a current ratio of 5.26, with Debt / Equity ratio of 45.56%
Current Ratio5.26
Quick Ratio4.56
Debt to Market Cap0.61
Net Debt to EBITDA-0.42
Interest Coverage Ratio-3.19
Taxes
In the past 12 months, Apyx Medical has paid 252.00K in taxes.
Income Tax252.00K
Effective Tax Rate-0.01
Enterprise Valuation
Apyx Medical EV to EBITDA ratio is -3.76, with an EV/FCF ratio of -3.37.
EV to Sales1.31
EV to EBITDA-3.76
EV to Free Cash Flow-3.37
EV to Operating Cash Flow-3.50
Balance Sheet
Apyx Medical has $31.01M in cash and marketable securities with $4.79M in debt, giving a net cash position of -$26.22M billion.
Cash & Marketable Securities$31.01M
Total Debt$4.79M
Net Cash-$26.22M
Net Cash Per Share-$0.69
Tangible Book Value Per Share$0.40
Margins
Gross margin is 51.59%, with operating margin of -39.18%, and net profit margin of -48.78%.
Gross Margin51.59%
Operating Margin-39.18%
Pretax Margin-48.45%
Net Profit Margin-48.78%
EBITDA Margin-34.93%
EBIT Margin-36.17%
Analyst Forecast
The average price target for Apyx Medical is $4.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.00
Price Target Upside139.52% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-6.27%
EPS Growth Forecast16.76%